Global Nimesulide Market Research Report 2022

Nimesulide is a relatively COX-2 selective, non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties. Its approved indications are the treatment of acute pain, the symptomatic treatment of osteoarthritis and primary dysmenorrhoea in adolescents and adults above 12 years old. Due to concerns about the risk of hepatotoxicity, nimesulide has been withdrawn from market in many countries.
Due to the COVID-19 pandemic, the global Nimesulide market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Nimesulide market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Nimesulide landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Tablets accounting for % of the Nimesulide global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Chronic Arthritis segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Nimesulide include Helsinn, Therabel, Boehringer Ingelheim, Merck, Roche, Novartis, Medea Research, Chinoin and GSK, etc. In terms of revenue, the global 3 largest players have a % market share of Nimesulide in 2021.
This report focuses on Nimesulide volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Nimesulide market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Nimesulide Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Tablets
Capsule
Granules
Other
Segment by Application
Chronic Arthritis
Primary Dysmenorrhea
Traumatic Pain
Post-Operative Pain
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Helsinn
Therabel
Boehringer Ingelheim
Merck
Roche
Novartis
Medea Research
Chinoin
GSK
Alter
Bayer
Rafa Laboratories
Grunenthal
Pfizer
Sanofi
Italfarmaco
Lepu Pharmaceutical
Nanchang Feihong Pharmaceutical
Sinopharm
Guangdong Longxin Pharmaceutical
Kangzhi Pharmaceutical
Hubei Shubang Pharmaceutical
Mudanjiang Lingtai Pharmaceutical
Guizhou Jisheng Pharmaceutical
Tianjin Hezhi Pharmaceutical Group
Guangdong Yishu Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Hainan Huluwa Pharmaceutical
Nanjing Zhengke Pharmaceutical